Last week, Washington University researchers published results of a study that represent a key step toward a blood test to diagnose people on track to develop Alzheimers before symptoms arise
Illegal weight-loss medicines containing semaglutide and tirzepatide were seized in South Africa after inspections uncovered serious safety, quality, and compliance issues.